Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
BRWD1 antisense RNA 1 (BRWD1-AS1) is a long non-coding RNA (lncRNA) gene located on chromosome 21, overlapping the BRWD1 locus; it is part of the lncRNA class and functions as an antisense RNA. BRWD1-AS1 is thought to regulate gene expression of its neighboring protein-coding gene BRWD1, likely via mechanisms that involve transcriptional interference, chromatin modification, or modulation of epigenetic states[1][2][3]. The clinical relevance of BRWD1-AS1 is limited, but some genomic studies have associated its locus with autism spectrum disorder[1]. Unlike conventional therapeutic protein targets, BRWD1-AS1 is not targeted by approved drugs nor described as a biomarker or a direct disease modifier. Its molecular role fits within the broader landscape of antisense and non-coding RNAs in gene regulation, where such molecules can act locally (in cis) or, rarely, in trans to affect the expression of adjacent or distant genetic elements[2]. If you need information about the protein-coding gene BRWD1 or its associated protein functions, please clarify, as this entry refers to the non-protein-coding antisense RNA transcript overlapping the BRWD1 locus.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on BRWD1 antisense RNA 1 (BRWD1-AS1).